RESEARCH The name might suggest more than one but for years, the autoimmune disease sclerosis (MS) has been combated as one profile with a variety of symptoms. The primary treatment has been beta-interferon, which has mixed results among patients. Some manifest quite unpleasant symptoms from the treatment, making it intolerable.
Scientists at Standford University School of Medicine published research in Nature Medicine supporting the discovery of two types of MS that each react differently to the standard treatment. Tests involving animal models were replicated among humans over a two-year study.
According to senior study author Lawrence Steinman, M.D. of the Neurology and Neurological Sciences Department at the Stanford University School of Medicine: "By making these distinctions in large human studies, people with multiple sclerosis might someday be able to take a simple blood test to see whether they are likely to respond to treatment with the standard multiple-sclerosis therapy."
Read complete 2010 article at CNN Health.